We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




AI-Powered Probe Aids POCUS Diagnosis and Care

By HospiMedica International staff writers
Posted on 02 Sep 2021
A new ultrasound linear probe designed for extremity imaging assists central line placement, nerve blocks, and guides joint injections.

The EchoNous (Redmond, WA, USA) Lexsa is a new 128-channel linear probe intended for ultrasound imaging of the lungs, vasculature, nervous, and musculoskeletal systems, and is the third probe of the EchoNous artificial-intelligence (AI) powered Kosmos imaging platform. More...
The Lexsa complements the Torso, which combines electrocardiogram (ECG), auscultation, and both continuous and pulsed wave Doppler capabilities; and the Torso-One, a slimmer version of the Torso scanner that offers only ultrasound imaging, without the additional ECG and stethoscope readings.

As its forerunners, the Lexsa connect to EchoNous’ Kosmos Bridge, which can be accessed via an Android S6 tablet--with S7 available soon--to produce high-definition (HD) image quality POCUS scans. The Kosmos Bridge, in turn, automatically saves and exports the scans to Kosmos AI, a proprietary software suite comprised of multiple AI algorithms that analyses the images, and also guides users through the scanning process with animated diagrams and automated grading and labelling.

“Lexsa will broaden the application of our Kosmos imaging platform beyond its current focus on cardiology, abdominal, and pulmonology, enabling entry into other departments that require linear capabilities for diagnosis or interventional use,” said CEO Kevin Goodwin. “Already favored for its built-in AI guidance and mapping around heart and lung structures, Kosmos will now gain traction as the ideal POCUS tool across multiple healthcare specialties.”

Hand-held POCUS systems are becoming more and more common, with new systems being offered by Butterfly Network (New York, NY, USA), Exo (Redwood City, CA, USA), and GE Healthcare (Chicago, IL, USA).

Related Links:
EchoNous
Butterfly Network
GE Healthcare



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Newborn Hearing Screener
ALGO 7i
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.